MC2 Biotek becomes MC2 Therapeutics
POSTED: December 15, 2016
MC2 Biotek, a clinical stage emerging specialty pharmaceutical company focusing on dermatology and ophthalmology, today announced that it has changed its name to MC2 Therapeutics.
Jesper J. Lange, President of MC2 ...
READ FULL ARTICLE >
EMA Paediatric Committee (PDCO) granted a waiver for MC2-03 PAD ™ Eye Drop
POSTED: September 29, 2016
Acceptance of this waiver for the Paediatric Investigation Plan (PIP) paves the way for the potential submission of a Marketing Authorization Application (MAA) in Europe following completion of the ongoing ...
READ FULL ARTICLE >
MC2 Biotek to present at ARVO
POSTED: May 1, 2016
MC2 Biotek, a clinical stage specialty pharmaceutical company focused on the development and commercialization of topical drugs that addresses the major problem of non-compliance of otherwise highly efficacious ...
READ FULL ARTICLE >
